Skip to main content
SpringerLink
Log in
Book cover

Hepatology Principles and Practice pp 519–540Cite as

Alcohol-induced liver damage

  • Chapter

  • 1545 Accesses

Keywords

  • Fatty Liver
  • Alcoholic Liver Disease
  • Alcoholic Hepatitis
  • Alcoholic Cirrhosis
  • Alcoholic Liver Cirrhosis

These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

This is a preview of subscription content, access via your institution.

Chapter
USD   29.95
Price excludes VAT (Canada)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   149.00
Price excludes VAT (Canada)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Achord, J.L.: Malnutrition and the role of nutritional support in alcoholic liver disease. Amer. J. Gastroenterol. 1987; 82: 1–7

    CAS  Google Scholar 

  2. Agarwal, D.P. Goedde, H.W.: Medicobiological and genetic studies on alcoholism. Role of metabolic variation and ethnicity on drinking habits, alcohol abuse and alcohol-related mortality. Clin. Invest. 1992; 70: 465–477

    CrossRef  CAS  Google Scholar 

  3. Akriviadis, E., Botla, R., Briggs, W., Han, S., Reynolds, T., Shakil, O.: Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology 2000; 119: 1637–1648

    CrossRef  CAS  PubMed  Google Scholar 

  4. Arico, S., Galatola, G., Tabone, M., Corrao, G.: Amount and duration of alcoholic intake in patients with chronic liver disease: an Italian multicentre study. Ital. J. Gastroenterol. 1994; 26: 59–65

    CAS  PubMed  Google Scholar 

  5. Arteel, G., Marsano, I., Mendez, C., Bentley, F., McClain, C.J.: Advances in alcoholic liver disease. Best Pract. Clin. Gastroenterol. 2003; 17: 625–647

    CAS  Google Scholar 

  6. Baldi, E., Burra, P., Plebani, M., Salvagnini, M.: Serum malondialdehyde and mitochondrial aspartate aminotransferase activity as markers of chronic alcohol intake and alcoholic liver disease. Ital. J. Gastroenterol. 1993; 25: 429–432

    CAS  PubMed  Google Scholar 

  7. Baptista, A., Bianchi, L., de Groote, J., Desmet, V.J., Gedigk, P., Korb, G., MacSween, R.N.M., Popper, H., Poulsen, H., Scheuer, P.J., Schmid, M., Thaler, H., Wepler, W.: Alcoholic liver disease: morphological manifestations. Review by an International Group. Lancet 1981/I: 707–711

    Google Scholar 

  8. Bassendine, M.F., Day, C.P.: The inheritance of alcoholic liver disease. Baill. Clin. Gastroenterol. 1998; 12: 317–335

    CAS  Google Scholar 

  9. Bell, H., Skinningsrud, A., Raknerud, N., Try, K.: Serum ferritin and transferrin saturation in patients with chronic alcoholic and non-alcoholic liver diseases. J. Intern. Med. 1994; 236: 315–322

    CAS  PubMed  Google Scholar 

  10. Bellis, L., Castelacci, R., Montagnese, F., Festuccia, F., Corvisieri, P., Puoti, C.: Hepatic venous pressure gradient determination in patients with hepatitis C virus-related and alcoholic cirrhosis. Eur. J. Gastroenterol. Hepatol. 2003; 15: 1085–1089

    PubMed  Google Scholar 

  11. Bird, G.L.A., Sheron, N., Goka, A.K.J., Alexander, G.J., Williams, R.: Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann. Intern. Med. 1990; 112: 917–920

    CAS  PubMed  Google Scholar 

  12. Black, M., Tavill, A.S.: Corticosteroids in severe alcoholic hepatitis. Ann. Intern. Med. 1989; 110: 677–680

    CAS  PubMed  Google Scholar 

  13. Bode, J.C., Kruse, G., Mexas, P., Martini, G.A.: Alkoholfettleber, Alkoholhepatitis und Alkoholzirrhose. Trinkverhalten und Häufigkeit klinischer, klinisch-chemischer und histologischer Befunde bei 282 Patienten. Dtsch. Med. Wschr. 1984; 109: 1516–1521

    CAS  PubMed  Google Scholar 

  14. Bosron, W.F., Ehrig, T., Li, T.-K.: Genetic factors in alcohol metabolism and alcoholism. Semin. Liver Dis. 1993; 13: 126–135

    CAS  PubMed  Google Scholar 

  15. Bradford, B.U., Enomoto, N., Ikejima, K., Rose, M.L., Bojes, H.K., Forman, D.T., Thurman, R.G.: Peroxisomes are involved in the swift increase in alcohol metabolism. J. Pharm. Exper. Ther. 1999; 288: 254–259

    CAS  Google Scholar 

  16. Bradlow, A., Mowat, A.G.: Dupuytren’s contracture and alcohol. Ann. Rheum. 1986; 45: 304–309

    CAS  Google Scholar 

  17. Brillanti, S., Masci, C., Siringo, S., di Febo, G., Miglioli, M., Barbara, L.: Serological and histological aspects of hepatitis C virus infection in alcoholic patients. J. Hepatol. 1991; 13: 347–350

    CrossRef  CAS  PubMed  Google Scholar 

  18. Caballeria, J.: First-pass metabolism of ethanol: its role as determinant of blood alcohol levels after drinking. Hepato-Gastroenterol. 1992; 39: 62–66

    CAS  Google Scholar 

  19. Caldwell, St.H., Jeffers, L.J., Ditomaso, A., Millar, A., Clark, R.M., Rabassa, A., Reddy, R., de Medina, M., Schiff, E.R.: Antibody to hepatitis C is common among patients with alcoholic liver disease with and without risk factors. Amer. J. Gastroenterol. 1991; 86: 1219–1223

    CAS  Google Scholar 

  20. Carithers, R.L. jr.; Herlong, H.F., Diehl, A.M., Shaw, E.W., Combes, B., Fallon, H.J., Maddrey, W.C.: Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial. Ann. Intern. Med. 1989; 110: 685–690

    PubMed  Google Scholar 

  21. Chan, A.W.K., Welte, F.W., Whitney, R.B.: Identification of alcoholism in young adults by blood chemistries. Alcohol 1987; 4: 175–179

    CrossRef  CAS  PubMed  Google Scholar 

  22. Chedid, A., Mendenhall, C.L., Tosch, T., Chen, T., Rabin, L., Garcia-Pont, P., Goldberg, S.J., Kiernan, T., Seeff, L.B., Sorrell, M., Tamburro, C., Weesner, R.E., Zetterman, R.: Significance of megamitochondria in alcoholic liver disease. Gastroenterology 1986; 90: 1858–1864

    CAS  PubMed  Google Scholar 

  23. Chedid, A., Mendenhall, C.L., Gartside, P., French, S.W., Chen, T., Rabin, L.: Prognostic factors in alcoholic liver disease. Amer. J. Gastroenterol. 1991; 86: 210–216

    CAS  Google Scholar 

  24. Chevaux, F., Fontolliet, C., Hofstetter, J.R.: Hépatite éthylique: evaluation histo-clinique. Schweiz. Med. Wschr. 1981; 11: 801–802

    Google Scholar 

  25. Christensen, E.: Alcoholic hepatitis — glucocorticosteroids or not? J. Hepatol. 2002; 36: 547–548

    CrossRef  PubMed  Google Scholar 

  26. Clark, S.A., Angus, H.B., Cook, H.B., George, P.M., Oxner, R.B.G., Fraser, R.: Defenestration of hepatic sinusoids as a cause of hyperlipoproteinaemia in alcoholics. Lancet 1988/II: 1225–1227

    Google Scholar 

  27. Colombat, M., Charlotte, F., Ratzin, V., Poynard, T.: Portal lymphocytic infiltrate in alcoholic liver disease. Hum. Path. 2002; 33: 1170–1174

    PubMed  Google Scholar 

  28. Cortez-Pinto, H., Alexandrino, P., Camilo, M.E., Gouveia-Oliveira, A., Santos, P.M., Alves, M.M., Moura, M.C.: Lack of effect of colchicines in alcoholic cirrhosis: Final results of a double blind randomized trial. Eur. J. Gastroenterol. Hepatol. 2002; 14: 377–381

    CrossRef  CAS  PubMed  Google Scholar 

  29. Crabb, D.W.: Biological markers for increased risk of alcoholism and for quantitation of alcohol consumption. J. Clin. Invest. 1990; 85: 311–315

    CAS  PubMed  Google Scholar 

  30. Day, C.P., Yeaman, S.J.: The biochemistry of alcohol-induced fatty liver. Biochem. Biophys. Acta 1994; 1215: 33–48

    CAS  PubMed  Google Scholar 

  31. De Feo, T.M., Fargion, S., Duca, L., Mattioli, M., Cappellini, M.D., Sampietro, M., Cesana, B.M., Fiorelli, G.: Carbohydrate-deficient transferrin, a sensitive marker of chronic alcohol abuse, is highly influenced by body iron. Hepatology 1999; 29: 658–663

    PubMed  Google Scholar 

  32. Denk, H., Lackinger, E.: Veränderungen des Intermediärfilament-Zytoskeletts der Leberzelle beim alkoholischen Leberschaden. Wien. Klin. Wschr. 1985; 97: 354–358

    CAS  PubMed  Google Scholar 

  33. Denk, H., Stumptner, C., Zatloukal, K.: Mallory bodies revisited. J. Hepatol. 2000; 32: 689–702

    CrossRef  CAS  PubMed  Google Scholar 

  34. Diehl, A.M.: Alcoholic liver disease. Med. Clin. North. Amer. 1989; 73: 815–830

    CAS  Google Scholar 

  35. Dilger, K., Metzler, J., Bode, J.C., Klotz, U.: CYP 2 E1 activity in patients with alcoholic liver disease. J. Hepatol. 1997; 27: 1009–1014

    CrossRef  CAS  PubMed  Google Scholar 

  36. Faller, J., Fox, I.H.: Ethanol-induced hyperuricemia. New Engl. J. Med. 1982; 307: 1598–1602

    CAS  PubMed  Google Scholar 

  37. Fantozzi, R., Caramelli, L., Ledda, F., Moroni, F., Masini, E., Blandina, P., Botti, P., Peruzzi, S., Zorn, A.M., Mannaioni, P.F.: Biological markers and therapeutic outcome in alcoholic disease: a twelve-year survey. Klin. Wschr. 1987; 65: 27–33

    CrossRef  CAS  PubMed  Google Scholar 

  38. Fong, T.-L., Kanel, G.C., Conrad, A., Valinluck, B., Charboneau, F., Adkins, R.H.: Clinical significance of concomitant hepatitis C infection in patients with alcoholic liver disease. Hepatology 1994; 19: 554–557

    CAS  PubMed  Google Scholar 

  39. French, S.W.: Mechanisms of alcoholic liver injury. Canad. J. Gastroenterol. 2000; 14: 327–332

    CAS  Google Scholar 

  40. Frezza, M., di Padova, C., Pozzato, G., Terpin, M., Baraona, E., Lieber, C.S.: High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. New Engl. J. Med. 1990; 322: 95–99

    CAS  PubMed  Google Scholar 

  41. Gellert, J.: Interaktionen von Medikamenten bei Alkoholikern. Dtsch. Med. Wschr. 1987; 112: 268–269

    CAS  PubMed  Google Scholar 

  42. Gertsch, P.: Transplantation hépatique chez le cirrhotique alcoolique: arguments pour. Schweiz. Med. Wschr. 1992; 122: 631–633

    CAS  PubMed  Google Scholar 

  43. Gjerde, H., Johnsen, J., Bjorneboe, A., Bjorneboe, G.-E.A.A., Morland, J.: A comparison of serum carbohydrate-deficient transferrin with other biological markers of excessive drinking. Scand. J. Lab. Invest. 1988; 48: 1–6

    CAS  Google Scholar 

  44. Goedde, H.W., Agarwal, D.P., Fritze, G.: Frequency of ALDH2 and ALDH5 genotypes in different populations and implications for alcohol sensitivity and alcohol drinking habits. Hum. Genet. 1992; 88: 344–346

    CrossRef  CAS  PubMed  Google Scholar 

  45. Goldin, R.: The pathogenesis of alcoholic liver disease. Int. J. Exp. Path. 1994; 75: 71–78

    CAS  Google Scholar 

  46. Goodman, Z.D., Ishak, K.G.: Occlusive venous lesions in alcoholic liver disease. A study of 200 cases. Gastroenterology 1982; 83: 786–796

    CAS  PubMed  Google Scholar 

  47. Gubbins, G.P., Moritz, T.E., Marsano, L.S., Talwalkar, R., McClain, C.J., Mendenhall, C.L., VA-Group: Helicobacter pylori is a risk factor for hepatitic encephalopathy in acute alcoholic hepatitis: the ammonia hypothesis revisited. Amer. J. Gastroenterol. 1993; 88: 1906–1910

    CAS  Google Scholar 

  48. Haber, P.S., Warner, R., Seth, D., Gorrell, M.D., McCaughan, G.W.: Pathogenesis and management of alcoholic hepatitis (review). J. Gastroenterol. Hepatol. 2003; 18: 1332–1344

    CrossRef  CAS  PubMed  Google Scholar 

  49. Han, S.H.B., Rice, S., Cohen, S.M., Reynolds, T.B., Fong, T.L.: Duplex Doppler ultrasound of the hepatic artery in patients with acute alcoholic hepatitis. J. Clin. Gastroenterol. 2002; 34: 573–577

    CrossRef  PubMed  Google Scholar 

  50. Hall, P.M. de la: The pathological spectrum of alcoholic liver disease. Pathology 1985; 17: 209–218

    CAS  PubMed  Google Scholar 

  51. Hayes, P.C., Bell, D., Plevris, J.N., Dawes, J., Bouchier, I.A.D.: Free radical production and neutrophil activation in the pathogenesis of alcoholic liver disease. Eur. J. Gastroenterol. 1989; 1: 101–105

    Google Scholar 

  52. Hessel, F.P., Mitzner, S.R., Rief, J., Guellstorff, B., Steiner, S., Wasem, J.: Economic evaluation and 1-year survival analysis of MARS in patients with alcoholic liver disease. Liver Internat. 2003; 23: 66–72

    Google Scholar 

  53. Hill, D.B., McClain, C.J.: Anti-TNF therapy in alcoholic hepatitis (editorial). Amer. J. Gastroenterol. 2004; 99: 261–263

    Google Scholar 

  54. Hintze, G., Cüppers, H.J., Mokry, H., Hein, D., Köbberling, J.: Die alkoholische Ketoacidose. Eine wichtige Differentialdiagnose zur diabetischen Ketoacidose. Dtsch. Med. Wschr. 1988; 113: 725–727

    CAS  PubMed  Google Scholar 

  55. Horn, T., Christoffersen, P., Henriksen, J.H.: Alcoholic liver injury: Defenestration in noncirrhotic livers — a scanning electron microscopic study. Hepatology 1987; 7: 77–82

    CAS  PubMed  Google Scholar 

  56. Hultberg, B., Isaksson, A., Berglund, M., Moberg, A.-L.: Serum β-hexosaminidase isoenzymze: a sensitive marker for alcohol abuse. Alcohol. Clin. Exp. Res. 1991; 15: 549–552

    CAS  PubMed  Google Scholar 

  57. Imperiale, T.F., McCullough, A.J.: Do corticosteroids reduce mortality from alcoholic hepatitis? A meta-analysis of the randomized trials. Ann. Intern. Med. 1990; 113: 299–307

    CAS  PubMed  Google Scholar 

  58. Ishii, H., Ebihara, Y., Okuno, F., Munakata, Y., Takagi, T., Arai, M., Shigeta, S., Tsuchiya, M.: γ-Glutamyl transpeptidase activity in liver of alcoholics and its histochemical localization. Alcohol. Clin. Exper. Res. 1986; 10: 81–85

    CAS  Google Scholar 

  59. Israel, Y., Orrego, H., Niemelae, O.: Immune responses to alcohol metabolites: pathogenic and diagnostic implications. Semin. Liver Dis. 1988; 8: 81–90

    CAS  PubMed  Google Scholar 

  60. Isselbacher, K.J.: Metabolic and hepatic effects of alcohol. New. Engl. J. Med. 1977; 296: 612–616

    CAS  Google Scholar 

  61. Jacobs, R.M., Sorrell, M.F.: The role of nutrition in the pathogenesis of alcoholic liver disease. Semin. Liver Dis. 1981; 1: 244–253

    CAS  PubMed  Google Scholar 

  62. Jalan, R., Sen, S., Steiner, C., Kapoor, D., Alisa, A., Williams, R.: Extracorporeal liver support with molecular adsorbent recirculating system in patients with severe acute alcoholic hepatitis. J. Hepatol. 2003; 38: 24–31

    CrossRef  CAS  PubMed  Google Scholar 

  63. Junge, J., Horn, T., Vyberg, M., Christoffersen, P., Svendsen, L.B.: The pattern of fibrosis in the acinar zone 3 areas in early alcoholic liver disease. J. Hepatol. 1991; 12: 83–86

    CrossRef  CAS  PubMed  Google Scholar 

  64. Kagata, Y., Okudaira, M., Uchikoshi, T., Nakano, M.: Histological study on alcoholic liver disease. Acta Hepatol. Japon. 1993: 34: 710–717

    Google Scholar 

  65. Kearns, P.J., Young, H., Garcia, G., Blaschke, T., O’Hanlon, G., Rinki, M., Sucher, K., Gregory, P.: Accelerated improvement of alcoholic liver disease with enteral nutrition. Gastroenterology 1992; 102: 200–205

    CAS  PubMed  Google Scholar 

  66. Keshavarzian, A., Holmes, E.W., Patel, M., Iber, F., Fields, J.Z., Pethkar, S.: Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage. Amer. J. Gastroenterol. 1999; 94: 200–207

    CAS  Google Scholar 

  67. Kuntz, E.: Alkohol als soziale und ökonomische Belastung. Münch. Med. Wschr. 1984; 126: 549–552

    Google Scholar 

  68. Laskin, C.A., Vidins, E., Blendis, L.M., Soloninka, C.A.: Autoantibodies in alcoholic liver disease. Amer. J. Med. 1990; 89: 129–133

    CAS  PubMed  Google Scholar 

  69. Lauterburg, B.H.: Pathogenese der äthylischen Hepatopathie. Schweiz. Med. Wschr. 1992; 122: 609–613

    CAS  PubMed  Google Scholar 

  70. Lelbach, W.K.: Cirrhosis in the alcoholic and its relation to the volume of alcohol abuse. Ann. NY Acad. Sci. 1975; 252: 85–105

    CAS  PubMed  Google Scholar 

  71. Lester, R., Eagon, P.K., van Thiel, D.H.: Feminization of the alcoholic: the estrogen/testosterone ratio (E/T). Gastroenterology 1979; 76: 415–417

    CAS  PubMed  Google Scholar 

  72. Li, J., Kim, C., Leo, A.M., Mak, K.M., Rojkind, M., Lieber, C.S.: Polyunsaturated lecithin prevents acetaldehyde-mediated hepatic collagen accumulation by stimulating collagenase activity in cultured lipocytes. Hepatology 1992; 15: 373–381

    CAS  PubMed  Google Scholar 

  73. Lieber, C.S.: Biochemical factors in alcoholic liver disease. Semin. Liver Dis. 1993; 3: 136–153

    Google Scholar 

  74. Lieber, C.S., Robins, S.J., Li, J.J., DeCarli, L.M., Mak, K.M., Fasulo, J.M., Leo, M.A.: Phosphatidylcholine protects against fibrosis and cirrhosis in the baboon. Gastroenterology 1994; 106: 152–159

    CAS  PubMed  Google Scholar 

  75. Lieber, C.S.: Hepatic and metabolic effects of ethanol: pathogenesis and prevention. Ann. Med. 1994; 26: 325–330 · Ethanol metabolism, cirrhosis and alcoholism. Clin. Chim. Acta 1997; 257: 59–84 · Role of oxidative stress and antioxidant therapy in alcoholic and non-alcoholic liver diseases. Adv. Pharmacol. 1997; 38: 601–628

    CAS  PubMed  Google Scholar 

  76. Lieber, C.S.: Alcoholic liver disease: new insights in pathogenesis lead to new treatments. J. Hepatol. 2000; 32(Suppl. 1): 113–128

    CAS  PubMed  Google Scholar 

  77. Lindros, K.O.: Alcoholic liver disease: pathobiological aspects. J. Hepatol. 1995; 23(Suppl. 1): 7–15

    CAS  PubMed  Google Scholar 

  78. Lotterer, E., Gressner, A.M., Kropf, J., Grobe, E., von Knebel, D., Bircher, J.: Higher levels of serum aminoterminal type III procollagen peptide, and laminin in alcoholic than in nonalcoholic cirrhosis of equal severity. J. Hepatol. 1992; 14: 71–77

    CrossRef  CAS  PubMed  Google Scholar 

  79. Lucey, M.R., Beresford, T.P.: Alcoholic liver disease: to transplant or not to transplant? Alcohol Alcoholism 1992; 27: 103–108

    CAS  Google Scholar 

  80. Lumeng, L., Crabb, D.W.: Genetic aspects and risk factors in alcoholism and alcoholic liver disease. Gastroenterology 1994; 107: 572–578

    CAS  PubMed  Google Scholar 

  81. Lumeng, L., Crabb, D.W.: Alcoholic liver disease. Curr. Opin. Gastroenterol. 2001; 17: 211–220

    CrossRef  CAS  Google Scholar 

  82. Maddrey, W.C.: Alcoholic hepatitis: clinicopathologic features and therapy. Semin. Liver. Dis. 1988; 8: 91–102

    CAS  PubMed  Google Scholar 

  83. Madhotra, R., Gilmore, I.T.: Recent developments in the treatment of alcoholic hepatitis. Quart. J. Med. 2003; 96: 391–400

    CAS  Google Scholar 

  84. Maher, J.J.: Hepatic fibrosis caused by alcohol. Semin. Liver Dis. 1990; 10: 66–74

    CAS  PubMed  Google Scholar 

  85. Mallach, H.J., Pedal, I., Völz, T.: Über tödliche Alkoholvergiftungen. Med. Welt 1980; 31: 1657–1661

    CAS  PubMed  Google Scholar 

  86. Mathurin, P., Abdelnour, M., Ramond, M.J., Carbonell, N., Fartoux, L., Serfaty, L., Valla, D., Poupon, R., Chaput, J.C., Naveau, S.: Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone. Hepatology 2003; 36: 1363–1369

    Google Scholar 

  87. Matloff, D.S., Selinger, M.J., Kaplan, M.M.: Hepatic transaminase activity in alcoholic liver disease. Gastroenterology 1989; 78: 1389–1392

    Google Scholar 

  88. Mato, J.M., Camara, J., Fernandez-de-Paz, J., Caballeria, L., Coll, S., Caballero, A., Garcia-Buey, L., Beltran, J., Benita, V., Caballeria, J., Sola, R., Moreno-Otero, R., Barrao, F., Martin-Duce, A., Correa, J.A., Pares, A., Barrao, E., Garcia-Magaz, I., Puerta, J.L., Moreno, J., Boissard, G., Ortiz, P., Rodes, J.: S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. J. Hepatol. 1999; 30: 1081–1089

    CrossRef  CAS  PubMed  Google Scholar 

  89. Mayfield, D., McLeod, G., Hall, P.: The CAGE questionnaire: validation of a new alcoholism screening instrument. Amer. J. Psychiat. 1974; 131: 1121–1123

    CAS  PubMed  Google Scholar 

  90. McCullogh, A.J., O’Connor, J.F.B.: Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology. Amer. J. Gastroenterol. 1998; 93: 2022–2036

    Google Scholar 

  91. Mezey, E., Caballeria, J., Mitchell, M.C., Pares, A., Herlong, H.F., Rodes, J.: Effect of parenteral amino acid supplementation on short-term and long-term outcomes in severe alcoholic hepatitis: a randomized controlled trial. Hepatology 1991; 14: 1090–1096

    CrossRef  CAS  PubMed  Google Scholar 

  92. Mezey, E., Potter, J.J., Rennie-Tankersley, L., Caballeria, J., Pares, A.: A randomized placebo controlled trial of vitamin E for alcoholic hepatitis. J. Hepatol. 2004; 40: 40–46

    CrossRef  CAS  PubMed  Google Scholar 

  93. Michalak, S., Rousselet, M.C., Bedossa, P., Pilette, C., Chappard, D., Oberti, F., Gallois, Y., Cales, P.: Respective roles of porto-septal fibrosis and centrilobular fibrosis in alcoholic liver disease. J. Path. 2003; 201: 55–62

    PubMed  Google Scholar 

  94. Mills, P.R., Spooner, R.J., Russell, R.I., Boyle, P., MacSween, R.N.M.: Serum glutamate dehydrogenase as a marker of hepatocyte necrosis in alcoholic liver disease. Brit. Med. J. 1981; 283: 754–755

    CAS  Google Scholar 

  95. Müller, M.J.: Alcohol and body weight. Z. Gastroenterol. 1999; 37: 33–43

    PubMed  Google Scholar 

  96. Nalpas, B., Hispard, E., Thépot, V., Pot, St., Dally, S., Berthelot, P.: A comparative study between carbohydrate-deficient transferrin and gamma-glutamyltransferase for the diagnosis of excessive drinking in a liver unit. J. Hepatol. 1997; 27: 1003–1008

    CrossRef  CAS  PubMed  Google Scholar 

  97. Niemelä, O., Risteli, J., Blake, J.E., Risteli, L., Compton, K.V., Orrego, H.: Markers of fibrogenesis and basement membrane formation in alcoholic liver disease. Relation to severity, presence of hepatitis, and alcohol intake. Gastroenterology 1990; 98: 1612–1619

    PubMed  Google Scholar 

  98. Niemelä, O., Parkilla, S., Britton, R.S., Brunt, E., Bacon, B.: Hepatic lipid peroxidation in hereditary hemochromatosis and alcoholic liver injury. J. Lab. Clin. Med. 1999; 133: 451–460

    PubMed  Google Scholar 

  99. Nissenbaum, M., Chedid, A., Mendenhall, C., Gartside, P.: Prognostic significance of cholestatic alcoholic hepatitis. Dig. Dis. Sci. 1990; 35: 891–896

    CrossRef  CAS  PubMed  Google Scholar 

  100. Norton, R., Batey, R., Dwyer, T., MacMahon, St.: Alcohol consumption and the risk of alcohol-related cirrhosis in women. Brit. Med. J. 1987; 295: 80–82

    CAS  Google Scholar 

  101. Ohtomo, K., Baron, R.L., Dodd III, G.D., Federle M.P., Miller, W.J., Campbell, W.L., Cofner, S.R., Weber, K.M.: Confluent fibrosis in advanced cirrhosis: appearance at CT. Radiology 1993; 188: 31–35

    CAS  PubMed  Google Scholar 

  102. Orrego, H., Blake, J.E., Blendis, L.M., Medline, A.: Prognosis of alcoholic cirrhosis in the presence and absence of alcoholic hepatitis. Gastroenterology 1987; 92: 208–214

    CAS  PubMed  Google Scholar 

  103. Osorio, R.W., Ascher, N.L., Avery, M., Bacchetti, P., Roberts, J.P., Lake, J.R.: Predicting recidivism after orthotopic liver transplantation for alcoholic liver disease. Hepatology 1994; 20: 105–110

    CrossRef  CAS  PubMed  Google Scholar 

  104. Pares, A., Caballeria, J., Bruguera, M., Torres, M., Rode, J.: Histological course of alcoholic hepatitis. Influence of abstinence, sex and extent of hepatic damage. J. Hepatol. 1986; 2: 33–42

    CrossRef  CAS  PubMed  Google Scholar 

  105. Parés, A., Barrera, J.M., Caballeria, J., Ercilla, G., Bruguera, M., Caballeria, L., Castillo, R., Rodes, J.: Hepatitis C virus antibodies in chronic alcoholic patients: association with severity of liver injury. Hepatology 1990; 12: 1295–1299

    PubMed  Google Scholar 

  106. Parlesak, A., Schäfer, C., Schütz, T., Bode, J.C., Bode, C.: Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease. J. Hepatol. 2000; 32: 742–747

    CrossRef  CAS  PubMed  Google Scholar 

  107. Pequignot, G., Chabet, C., Eydoux, H., Courcoul, M.A.: Augmentation du risque de cirrhose en fonction de la ration d’alcohol. Rev. Alcohol. 1974; 20: 192–201

    Google Scholar 

  108. Pessione, F., Ramond, M.C., Peters, L., Pham, B.N., Batel, P., Rueff, B., Valla, D.C.: Five-year survival predictive factors in patients with excessive alcohol intake and cirrhosis. Effect of alcoholic hepatitis, smoking and abstinence. Liver Internat. 2003; 23: 45–53

    CAS  Google Scholar 

  109. Plevris, J.N., Hauer, J.L., Hayes, P.C., Bouchier, I,A.D.: The hands in alcoholic liver disease. Amer. J. Gastroenterol. 1991; 86: 467–471

    CAS  Google Scholar 

  110. Poynard, T., Aubert, A., Bedossa, P., Abella, A., Naveau, S., Paraf, F., Chaput, J.C.: A simple biological index for detection of alcoholic liver disease in drinkers. Gastroenterology 1991; 100: 1397–1402

    CAS  PubMed  Google Scholar 

  111. Poynard, T., Barthelemy, P., Fratte, S., Boudjema, K., Doffoel, M., Vanlemmens, C., Miguet, J.P., Mantion, G., Messner, M., Launois, B., Naveau, S., Chaput, J.C.: Evaluation of efficacy of liver transplantation in alcoholic cirrhosis by a case-control study and simulated controls. Lancet 1994; 344: 502–507

    CrossRef  CAS  PubMed  Google Scholar 

  112. Ramond, M.-J., Poynard, T., Rueff, B., Mathurin, P., Théodore, C., Chaput, J.-C., Benhamou, J.-P.: A randomized trial of prednisolone in patients with severe alcoholic hepatitis. New Engl. J. Med. 1992; 326: 507–512

    CAS  PubMed  Google Scholar 

  113. Rohner, A.: La transplantation hépatique dans la cirrhose alcoolique est-elle légitime? Schweiz. Med. Wschr. 1992; 122: 628–630

    CAS  PubMed  Google Scholar 

  114. Roine, R.P., Turpeinen, U., Ylikahri, R., Salaspuro, M.: Urinary dolichol — a new marker of alcoholism. Alcohol. Clin. Exp. Res. 1987; 11: 525–527

    CAS  PubMed  Google Scholar 

  115. Roine, R.P., Erikson, C.J.P., Ylikahri, R., Penttilä, A., Salaspuro, M.: Methanol as a marker of alcohol abuse. Alcohol. Clin. Exp. Res. 1989; 13: 172–175

    CAS  PubMed  Google Scholar 

  116. Rosman, A.S., Paronetto, F., Galvin, K., Williams, R.J., Lieber, C.S.: Hepatitis C virus antibody in alcoholic patients. Arch. Intern. Med. 1993; 153: 965–969

    CrossRef  CAS  PubMed  Google Scholar 

  117. Salaspuro, M.: Characteristics of laboratory markers in alcohol-related organ damage. Scand. J. Gastroenterol. 1989; 24: 769–780

    CAS  PubMed  Google Scholar 

  118. Savolainen, V., Perola, M., Lalu, K., Penttilä, A., Virtanen, I., Karhunen, P.J.: Early perivenular fibrogenesis’ precirrhotic lesions among moderate alcohol consumers and chronic alcoholics. J. Hepatol. 1995; 23: 524–531

    CrossRef  CAS  PubMed  Google Scholar 

  119. Schenker, S., Halff, G.A.: Nutritional therapy in alcoholic liver disease. Semin. Liver Dis. 1993; 13: 196–209

    CAS  PubMed  Google Scholar 

  120. Seitz, H.K., Egerer, G., Simanowski, U.A., Waldherr, R., Ecky, R., Agarwal, D.P., Goedde, H.W., v. Wartburg, J.-P.: Human gastric alcohol dehydrogenase activity: effect of age, sex, and alcoholism. Gut 1993; 34: 1433–1437

    CAS  PubMed  Google Scholar 

  121. Serra, M.A., Escudero, A., Rodriguez, F., del Olmo, J.A., Rodrigo, J.M.: Effect of hepatitis C virus infection and abstinence from alcohol on survival in patients with alcoholic cirrhosis. J. Clin. Gastroenterol. 2003; 36: 170–174

    CrossRef  PubMed  Google Scholar 

  122. Sharpe, P.C., McBride, R., Archbold, G.P.R.: Biochemical markers of alcohol abuse. Quart. J. Med. 1996; 89: 137–144

    CAS  Google Scholar 

  123. Sillanaukee, P.: The diagnostic value of a discriminant score in the detection of alcohol abuse. Arch. Path. Lab. Med. 1992; 116: 924–929

    CAS  PubMed  Google Scholar 

  124. Simanowski, U.A., Egerer, G., Oneta, C., Keil, T., Pares, X., Conradt, C., Arce, L., Waldherr, R., Stickel, F., Russell, R.M., Aderjan, R., Klee, F., Seitz, H.K.: Helicobacter pylori infection decreases gastric alcohol dehydrogenase activity and first-pass metabolism of ethanol in man. Digestion 1998; 59: 314–320

    CrossRef  CAS  PubMed  Google Scholar 

  125. Simon, D., Galambos, J.T.: A randomized controlled study of peripheral parenteral nutrition in moderate and severe alcoholic hepatitis. J. Hepatol. 1988; 7: 200–207

    CrossRef  CAS  PubMed  Google Scholar 

  126. Soyka, M., Gilg, T., von Meyer, L., Ora, I.: Methanolstoffwechsel bei chronischem Alkoholismus. Wien. Klin. Wschr. 1991; 103: 684–689

    CAS  PubMed  Google Scholar 

  127. Naveau, S., Chollet-Martin, S., Dharancy, S., Mathurin, P., Jouet, P., Piquet, M.A., Davion, T., Oberti, F., Broet, P., Emilie, D.: A doubleblind randomized controlled trial of infliximab associated with prednisolon in acute alcoholic hepatitis. Hepatology 2004; 39: 1390–1397

    CrossRef  CAS  PubMed  Google Scholar 

  128. Sprung, R., Bonte, W., Lesch, O.M.: Methanol — Ein bisher verkannter Bestandteil aller alkoholischen Getränke. Eine neue biochemische Annäherung an das Problem des chronischen Alkoholismus. Wien. Klin. Wschr. 1988; 100: 282–288

    CAS  PubMed  Google Scholar 

  129. Stibler, H.: Carbohydrate-deficient transferrin in serum: a new marker of potentially harmful alcohol consumption reviewed. Clin. Chem. 1991; 37: 2029–2037

    CAS  PubMed  Google Scholar 

  130. Stickel, F., Schuppan, D., Hahn, E.G., Seitz, H.K.: Cocarcinogenic effects of alcohol in hepatocarcinogenesis (review). Gut 2002; 51: 132–139

    CrossRef  CAS  PubMed  Google Scholar 

  131. Stickel, F., Hoehn, B., Schuppan, D., Seitz, H.K.: Review article: Nutritional therapy in alcoholic liver disease. Alim. Pharm. Ther. 2003; 18: 357–373

    CAS  Google Scholar 

  132. Sumino, Y., Kravetz, D., Kanel, G.C., McHutchinson, J.G., Reynolds, T.B.: Ultrasonographic diagnosis of acute alcoholic hepatitis “pseudoparallel channel sign” of intrahepatic artery dilation. Gastroenterology 1993; 105: 1477–1488

    CAS  PubMed  Google Scholar 

  133. Suri, S., Mitros, F.A., Ahluwalia, J.P.: Alcoholic foamy degeneration and a markedly elevated GGT. A case report and literature review. Dig. Dis. Sci. 2003; 48: 1142–1146

    CrossRef  CAS  PubMed  Google Scholar 

  134. Takase, S., Tsutsumi, M., Kawahara, H., Takada, N., Takada, A.: The alcohol-altered liver membrane antibody and hepatitis C virus infection in the progression of alcoholic liver disease. Hepatology 1993; 17: 9–19

    CrossRef  CAS  PubMed  Google Scholar 

  135. Tamburro, C.H., Lee, H.M.: Primary hepatic cancer in alcoholics. Clin. Gastroenterol. 1981; 10: 457–477

    CAS  PubMed  Google Scholar 

  136. Tanner, A.R., Bantock, I., Hinks, L., Lloyd, B., Turner, N.R., Wright, R.: Depressed selenium and vitamin E levels in an alcoholic population: possible relationship to hepatic injury through increased lipid peroxidation. Dig. Dis. Sci. 1986; 31: 1307–1312

    CrossRef  CAS  PubMed  Google Scholar 

  137. Thompson, R.P.H.: Alcohol nutrition and the liver. Eur. J. Gastroenterol. Hepatol. 1990; 2: 417–421

    Google Scholar 

  138. Tome, S., Lucey, M.R.: Review article: Current management of alcoholic liver disease. Aliment. Pharm. Ther. 2004; 19: 707–714

    CAS  Google Scholar 

  139. Van de Casteele, M., Zaman, Z., Zeegers, M., Servaes, R., Fevery, J., Nevens, F.: Blood antioxidant levels in patients with alcoholic liver disease correlate with the degree of liver impairment and are not specific to alcoholic liver injury itself. Alim. Pharm. Ther. 2002; 16: 985–992

    Google Scholar 

  140. Van de Wiel, A., van Hattum, J., Schuurman, H.-J., Kater, L.: Immunoglobulin A in the diagnosis of alcoholic liver disease. Gastroenterology 1988; 94: 457–462

    PubMed  Google Scholar 

  141. Viebahn, R., Lauchart, W.: Indikation zur Lebertransplantation bei Alkoholzirrhose. Chir. Gastroenterol. 1994; 10: 392–396

    Google Scholar 

  142. Volpi, E., Lucidi, P., Cruciani, G., Monacchia, F., Santoni, S., Reboldi, G., Brunetti, P., Bolli, G.B., de Feo, P.: Moderate and large doses of ethanol differentially affect hepatic protein metabolism in humans. J. Nutr. 1998; 128: 198–203

    CAS  PubMed  Google Scholar 

  143. Watson, R.R., Mohs, M.E., Eskelson, C., Sampliner, R.E., Hartmann, B.: Identification of alcohol abuse and alcoholism with biological parameters. Alcohol. Clin. Exp. Res. 1986; 10: 364–385

    CAS  PubMed  Google Scholar 

  144. Wegener, M., Neuhausen, P., Börsch, G., Ricken, D.: Bedeutung der Serumimmunglobuline für die Diagnose alkohol-induzierter Lebererkrankungen. Dtsch. Med. Wschr. 1986; 111: 1716–1720

    CAS  PubMed  Google Scholar 

  145. Wenzel, G., Kuklinski, B., Rühlmann, C., Ehrhardt, D.: Alkoholtoxische Hepatitis — eine „freie Radikale“-assoziierte Erkrankung. Letalitätssenkung durch adjuvante Antioxidanzientherapie. Z. Ges. Inn. Med. 1993; 48: 490–496

    CAS  PubMed  Google Scholar 

  146. Worner, T.M., Lieber C.S.: Perivenular fibrosis as precursor lesion of cirrhosis. J. Amer. Med. Ass. 1985; 254: 627–630

    CAS  Google Scholar 

  147. Zachara, B.A., Borowska, K., Koper, J., Rybakowski, J., Pilaczynska, E.: Selen-und Zinkgehalte im Serum bei chronischen Alkoholikern. Z. Ges. Hygiene 1988; 34: 187–189

    CAS  Google Scholar 

  148. Zieve, L.: Jaundice, hyperlipidemia and hemolytic anemia: a heretofore unrecognized syndrome associated with alcoholic fatty liver and cirrhosis. Ann. Intern. Med. 1958; 48: 471–496

    CAS  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and Permissions

Copyright information

© 2006 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

(2006). Alcohol-induced liver damage. In: Hepatology Principles and Practice. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-28977-1_28

Download citation

  • DOI: https://doi.org/10.1007/3-540-28977-1_28

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-28976-0

  • Online ISBN: 978-3-540-28977-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

search

Navigation